Back to top

Image: Bigstock

Top Ranked Momentum Stocks to Buy for December 26th

Read MoreHide Full Article

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, December 26th:

Apollo Investment Corporation : This business development company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.1% over the last 60 days.

Apollo Investment Corporation Price and Consensus

Apollo Investment's shares gained 6.3% over the last one month compared to S&P 500’s rise of 2.6%. The company possesses a Momentum Score of B.

Apollo Investment Corporation Price

American Outdoor Brands Corporation : This designer and manufacturer of firearms has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 9.5% over the last 60 days.

American Outdoor Brands Corporation Price and Consensus

American Outdoor Brands’ shares gained 7.9% over the last one month. The company possesses a Momentum Score of B.

American Outdoor Brands Corporation Price

Bristol-Myers Squibb Company (BMY - Free Report) : This manufacturer and distributor of biopharmaceutical products has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.4% over the last 60 days.

Bristol-Myers Squibb Company Price and Consensus

Bristol-Myers’ shares gained 11.3% over the last one month. The company possesses a Momentum Score of A.

Bristol-Myers Squibb Company Price

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

5 Stocks Set to Double

Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Bristol Myers Squibb Company (BMY) - free report >>

Published in